Ann: 2022 Annual Report, page-5

Thanks for the summaries Quiltman.

Looking at the new Top 20. Cozzi is no longer a substantial holder. C2 Ventures have a much larger stake, just under 20%. Not sure about the other moves, haven't looked closely.



From my understanding, what we still have to expect in the short term are as follows:

1. CONNEQT Pulse to be launched later this year. FDA looking to be due Nov/Dec
2. CONNEQT App (already FDA cleared) expected to be launched post FDA clearance of the Pulse
3. CONNEQT wearable aiming for launch start of next year before the trade show (I forget when that is?)
4. US listing, as stated in the SPP docs ("one does not appoint a US Broker unless the potential timing is near term")
5. Decentralised trials partnerships

Also, we may hear about the USD 7m+ in contracts currently in the pipeline. That should bolster up our CF.

Needless to say, the next few months have the potential to be massive IF all goes to plan.

DYOR IMO